Farallon Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-666,000	Closed	-$15.7M	–	175
2024 Q2	$15.7M	Buy	666,000 +200,000	+43%	+$4.7M	0.07%	72
2024 Q1	$17.7M	Buy	+466,000	New	+$17.7M	0.08%	73